This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Fondazione Istituto Italiano Di Tecnologia, Fondazione Per La Ricerca Sulla Fibrosi Cistica-on-Lus, Instituto Giannina Gaslini. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020-2021
Title: Francesco Berti: Innovator in Cystic Fibrosis Treatment
Introduction
Francesco Berti is a notable inventor based in Verona, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. With a total of 2 patents, his work focuses on developing innovative compounds that can improve the lives of those affected by this condition.
Latest Patents
Francesco Berti's latest patents include groundbreaking inventions aimed at treating cystic fibrosis. The first patent involves compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof. This invention further discloses a pharmaceutical composition comprising these compounds and their uses, particularly in modulating CFTR protein or ABC protein activities. The second patent also relates to heterocyclic derivatives for the treatment of cystic fibrosis, similarly focusing on compounds of Formula (I) and their pharmaceutical applications.
Career Highlights
Throughout his career, Francesco Berti has worked with esteemed organizations such as the Fondazione Istituto Italiano Di Tecnologia and the Instituto Giannina Gaslini. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Francesco has collaborated with notable colleagues, including Tiziano Bandiera and Fabio Bertozzi. These partnerships have enriched his research and have been instrumental in the development of his innovative patents.
Conclusion
Francesco Berti stands out as a dedicated inventor whose work in cystic fibrosis treatment showcases his commitment to improving healthcare. His innovative patents and collaborations reflect his significant impact on the field of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile